The client needs to obtain the patient view and preferences on clinical trial design, especially in regard to the burden of the trial, in- and exclusion criteria and readability of consent material

Case: Multi-Stakeholder Co-Creation on Real-World Evidence
Situation
A client wishes to submit an HTA dossier to a payer institution for a therapeutic indication with many other approved treatments already existing on the market. The client did not previously consult patients or patient organizations in the development of the Patient-Reported Outcomes data and is unsure how to approach it. The patient-relevance of the data has been questioned and is not well justified by the company.

Our Solution
- Identification of best partners among KOLs, allied health professionals and patient experts
- Co-creation session prepared and moderated by admedicum
- Full-day session jointly with the internal team
- Challenging status quo and identifying need-gap
- Brainstorming opportunities for further clinical and health economic evidence
- Conceptualizing a plan for additional QoL/PROMs data
- Co-create more patient-relevant endpoints acceptable to the company
Results
-
HTA relevant Real-World Evidence (RWE) ideas as a basis for internal decision making in future data collection